This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Myasthenias
Information about Myasthenias: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Myasthenias
Most recent studies have shown that Myasthenias shares some biological mechanisms with arthritis, autoimmune-diseases, autoimmune-reaction, blepharoptosis, generalized-myasthenia, hyperplasia, lupus-erythematosus-systemic, multiple-sclerosis, muscle-weakness, myasthenia-gravis, myopathy, neoplasms, neuromuscular-diseases, ocular-myasthenia, rheumatoid-arthritis, sclerosis, thymoma, thymus-hyperplasia, thymus-neoplasms, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Myasthenias, and have been seen in publications frequently: Aging, Cell Activation, Cell Proliferation, Complement Activation, Excretion, Hypersensitivity, Immune Response, Innervation, Localization, Lymphocyte Proliferation, Muscle Atrophy, Muscle Contraction, Pathogenesis, Reflex, Secretion, Sensitization, Synaptic Transmission, T Cell Activation, T Cell Proliferation, Tolerance Induction
Quite a number of genes have been found to play important roles in Myasthenias, such as ACHE, BCHE, C3, CD4, CD8A, CTLA4, HLA-DQA1, IFNG, IL10, IL2, IL4, IL6, MUSK, NOD2, POMC, TNF, TTN. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.